GUMDROP : CUA - A Multicenter Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer Who Have Failed Primary Androgen Deprivation Therapy

Created by Nancy Dawson, last modified on Jun 01, 2013
Description:The purpose of this study is to determine the safety and efficacy of enzalutamide vs. bicalutamide in asymptomatic or mildly symptomatic patients with prostate cancer who have disease progression despite primary androgen deprivation therapy.
Link:http://clinicaltrials.gov/ct2/show/NCT01664923
Site:Chesapeake Urology Associates
Principal Investigator: Fong Wang, M.D., PhD (415) 829-4150